What is Changmao Biochemical Engineering Co Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Changmao Biochemical Engineering Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Changmao Biochemical Engineering Co Enterprise Value Chart
Competitive Comparison of Changmao Biochemical Engineering Co's Enterprise Value
For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Changmao Biochemical Engineering Co's Enterprise Value Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Changmao Biochemical Engineering Co's Enterprise Value falls into.
Changmao Biochemical Engineering Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changmao Biochemical Engineering Co (HKSE:00954) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Changmao Biochemical Engineering Co's EV-to-EBIT for today is
Changmao Biochemical Engineering Co's current Enterprise Value is HK$668.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Changmao Biochemical Engineering Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-60.2 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Changmao Biochemical Engineering Co's EV-to-EBITDA for today is:
Changmao Biochemical Engineering Co's current Enterprise Value is HK$668.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Changmao Biochemical Engineering Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-60.2 Mil.
Changmao Biochemical Engineering Co's current Enterprise Value is HK$668.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Changmao Biochemical Engineering Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was HK$627.2 Mil.
Changmao Biochemical Engineering Co's current Enterprise Value is HK$668.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Changmao Biochemical Engineering Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-103.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changmao Biochemical Engineering Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Changmao Biochemical Engineering Co Business Description
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00954 has been successfully added to your 